2025. INTRAVENOUS FERRIC CARBOXYMALTOSE IN THE TREATMENT OF HEART FAILURE: EFFECTS ON PATIENTS WITH PRESERVED AND REDUCED EJECTION FRACTION. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. 6, 3 (Mar. 2025), e636266. DOI:https://doi.org/10.47820/recima21.v6i3.6266.